QUINMUNITY Trademark

Trademark Overview


On Thursday, January 6, 2022, a trademark application was filed for QUINMUNITY with the United States Patent and Trademark Office. The USPTO has given the QUINMUNITY trademark a serial number of 97205461. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 12, 2024. This trademark is owned by Pfizer Inc.. The QUINMUNITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use
quinmunity

General Information


Serial Number97205461
Word MarkQUINMUNITY
Filing DateThursday, January 6, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, January 10, 2022NEW APPLICATION ENTERED
Monday, January 10, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 12, 2022ASSIGNED TO EXAMINER
Wednesday, October 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 9, 2023SOU EXTENSION 1 FILED
Friday, June 9, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 12, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, February 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED